Dr Reddys Laboratories Share Price Today - Live Blog for June 18, 2025

The stock of Dr Reddys Laboratories Ltd is facing a -0.02% decline and is currently trading at ₹1,313.55 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd witnessed a -0.06% decrease in its share price, and it is currently trading at ₹1,312.85. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a substantial 0.02% increase in its share price and is currently trading at ₹1,316.15. This remarkable performance has caught the eye of investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,316.15 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd witnessed a notable 0.19% surge in its share price and is presently trading at ₹1,316.00, captivating the attention of market participants.

Dr Reddys Laboratories Ltd witnessed a substantial 0.04% increase in its share price and is currently trading at ₹1,314.05. This remarkable performance has caught the eye of investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.04% gain, with the share price now at ₹1,314.05. Notably, the stock's PE ratio stands at 19.4600, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd shares saw a -0.13% decrease, reaching a current market price of ₹1,312.20. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd suffered a -0.06% drop, and it's now trading at ₹1,313.90 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 0.06%. At this moment, it's actively trading at ₹1,315.80, presenting an enticing opportunity for those in the market.

Demonstrating a commendable 0.06% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,315.80. In terms of valuation, the stock maintains a PE ratio of 19.4600, while the industry PE ratio stands at 34.9501.

Dr Reddys Laboratories Ltd observed a -0.10% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,314.80. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a -0.03% decrease, reaching a current market price of ₹1,316.15. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.03%, reaching a current market price of ₹1,316.15. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.09% increase and currently trading at ₹1,317.60 per share. This upward trajectory is turning heads in the market.

With a -0.11% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,316.30. The stock is currently trading at a PE of 19.4600, while the industry PE is 34.9501, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd witnessed a substantial 0.34% increase in its share price and is currently trading at ₹1,315.80. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd share price has declined by -0.24%, and it's currently trading at ₹1,310.40. The stock maintains a PE of 19.4600, while the industry PE is 34.9501, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.07% increase and currently trading at ₹1,315.00 per share. Investors are taking notice of this upward momentum.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.08% increase and currently trading at ₹1,314.10 per share. This upward trajectory is turning heads in the market.

The stock of Dr Reddys Laboratories Ltd is facing a -0.30% decline and is currently trading at ₹1,312.70 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd observed a -0.08% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,315.00. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.14% in its share price, and it currently trades at ₹1,317.10 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.13%, and as of now, it's trading at ₹1,320.00 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd shares saw a -0.25% decrease, reaching a current market price of ₹1,318.35. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Following a noteworthy 0.06% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,320.95. When it comes to valuation, this stock has a PE ratio of 19.4600, with the industry PE ratio at 34.9501.

Dr Reddys Laboratories Ltd witnessed a -0.06% decrease in its share price, and it is currently trading at ₹1,318.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.4600, an ROE of 16.8559% and a debt to equity ratio of 0.1394.